Company Overview of AdvanDx, Inc.
AdvanDx, Inc., a biotech company, provides molecular diagnostic tests for the identification of pathogens causing critical infections in hospitalized patients. The company specializes in the molecular testing of positive blood cultures that enable clinical microbiology laboratories to report pathogen identification results earlier than with conventional testing methods. It offers QuickFISH (Fluorescence In Situ Hybridization) and PNA FISH tests for the identification of bacteria and yeast directly from positive blood cultures; XpressFISH, a platform that allows for the detection of resistance markers from positive blood cultures; and PNA Probes for ribosomal RNA sequences found in bacteria a...
Woburn, MA 01801
Founded in 2002
Key Executives for AdvanDx, Inc.
Chief Executive Officer and Director
Founder, Vice President of Research & Development and Director
Global Marketing Director
Compensation as of Fiscal Year 2016.
AdvanDx, Inc. Key Developments
OpGen, Inc., AdvanDx, Inc. - M&A Call
Jul 14 15
To discuss recent developments
AdvanDx, Inc. Receives FDA 510(K) Clearance for mecA XpressFISH
Nov 18 14
AdvanDx, Inc. announced that it has received U.S. Food and Drug Administration 510(k) clearance for its new mecA XpressFISH(TM) assay for the detection of methicillin-resistant and methicillin-susceptible Staphylococcus aureus (MRSA & MSSA) direct from blood culture samples. This phenotypic mRNA-targeting approach makes mecA XpressFISH unique in its mechanism of MRSA identification. mecA XpressFISH also provides results hours or days sooner than conventional laboratory methods which often require 48-72 hours. Drug resistance in MRSA is commonly conferred through expression of the bacterial mecA gene. mecA XpressFISH is a qualitative fluorescence in situ hybridization (FISH) assay that utilizes peptide nucleic acid (PNA) probes to bind and detect mecA messenger RNA (mRNA) sequences in blood cultures from patients infected with Staphylococcus aureus. Positive detection requires that the cells contain a functioning mecA gene.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create
or control the content. For inquiries, please contact Capital IQ directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries